Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2010, Vol. 4 Issue (1) : 101-105     DOI: 10.1007/s11684-010-0017-6
Research articles |
Genetic association between the polymorphism of cytosolic PLA2 gene family and schizophrenia
Qiong YU PhD,Xiang-Fei MENG PhD,Jie-Ping SHI,Ya-Qin YU PhD,
Department of Epidemiology and Biostatistics, Center of Medical Genomics, School of Public Health, Jilin University, Changchun 130021, China;
Download: PDF(76 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Abnormal phospholipid metabolism in the brain plays an important role in neuropsychiatric diseases. Phospholipase A2 (PLA2) is a crucial element for normal neuro-physiological function. This study aims to investigate the genetic association between the polymorphism of cytosolic phospholipase A2 (cPLA2) family genes and schizophrenia among Han Chinese in the northern part of China. The polymerase chain reaction-based ligase detection reaction (PCR-LDR) was applied to detect the genotype ten single nucleotide polymorphisms (SNPs) of cPLA2 family genes among 201 pedigrees consisting of fathers, mothers and affected offsprings with schizophrenia. The pedigrees were collected from 2000 to 2006. Haplotype relative risk (HRR) test, transmission disequilibrium test (TDT), haplotype transmission analysis and multiple locus analysis were conducted to analyze the genotyping data. The genotypic frequency of cPLA2 gene did not deviate from Hardy-Weinberg equilibrium either in case or control group. HRR and TDT showed that the ten SNPs were not associated with schizophrenia (P>0.05). Analysis for haplotype transmission showed that no haplotype system was associated with schizophrenia (P>0.05). The conditioning on allele (COA) and conditioning on gene (COG) tests showed disease associations with the haplotype of rs2162886-rs1668589, rs891014-rs1668589 and rs2307279-rs7542180 (χ2=6.913, P=0.032; χ2=8.393, P=0.015; χ2€=8.447, P=0.038). Our data suggest that many loci in the cPLA2 family genes may be associated with schizophrenia.
Keywords schizophrenia      cytosolic phospholipase A2      ligase detection reaction      polymorphism      
Issue Date: 05 March 2010
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-010-0017-6     OR     http://academic.hep.com.cn/fmd/EN/Y2010/V4/I1/101
World Health Organization. WHO Health Report 2001-Mental Health: new understanding,new hope. World Health Organization, 2001: 33–34
World Health Organization. Mental Health around the World: Stop Exclusion Dare toCare, World Mental Health Day. 2001
United Nations PopulationDivision. World Population Prospects: The2002 Revision, Volume III, The AnalyticalReport
Murray C, Lopez A. The GlobalBurden of Disease: A Comprehensive Assessment of Mortality and Disabilityfrom Diseases, Injuries and Risk Factors in 1990 and Projected to2020. Cambridge, MA: Harvard University Press, 1996
Klemm S, Rzanny R, Riehemann S, Volz H P, Schmidt B, Gerhard U J, Filz C, Schönberg A, Mentzel H J, Kaiser W A, Blanz B. Cerebral phosphatemetabolism in first-degree relatives of patients with schizophrenia. Am J Psychiatry, 2001, 158(6): 958–960

doi: 10.1176/appi.ajp.158.6.958
Bennett C N, Horrobin D F. Gene targets related to phospholipids and fatty acid metabolism inschizophrenia and other psychiatric disorders: an update. Prostaglandins Leukot Essent Fatty Acids, 2000, 63(1,2): 47–59
Macdonald D J, Boyle R M, Glen A C, Ross B M, Glen A I, Ward P E, McKinney S B, Peterkin M A. The investigation of cytosolicphospholipase A2 using ELISA. ProstaglandinsLeukot Essent Fatty Acids, 2004, 70(4): 377–381

doi: 10.1016/j.plefa.2003.12.013
Kinney D K, Jacobsen B, Jansson L. Winter birth and biologicalfamily history in adopted schizophrenics. Schizophr Res, 2000, 44(2): 95–103

doi: 10.1016/S0920-9964(99)00162-0
Wei J, Hemmings G P. A study of a genetic association between the PTGS2/PLA2G4A locusand schizophrenia. Prostaglandins LeukotEssent Fatty Acids, 2004, 70(4): 413–415

doi: 10.1016/j.plefa.2003.12.018
Hudson C J, Kennedy J L, Gotowiec A, Lin A, King N, Gojtan K, Macciardi F, Skorecki K, Meltzer H Y, Warsh J J, Horrobin D F. Genetic variant near cytosolicphospholipase A2 associated with schizophrenia. Schizophr Res, 1996, 21(2): 111–116

doi: 10.1016/0920-9964(96)00031-X
Yu Y, Tao R, Shi J, Zhang X, Kou C, Guo Y, Zhang X, Lin X, Liu S, Ju G, Xu Q, Shang H, Shen Y, Wei J. Agenetic study of two calcium-independent cytosolic PLA2 genes in schizophrenia. Prostaglandins Leukot and Essent Fatty Acids, 2005, 73(5): 351–354

doi: 10.1016/j.plefa.2005.07.003
Gattaz W F, Brunner J. Phospholipase A2 and the hypofrontality hypothesis of schizophrenia. Prostaglandins Leukot Essent Fatty Acids, 1996, 55(1,2): 109–113
Pae C U, Yu H S, Lee K U, Kim J J, Lee C U, Lee S J, Jun T Y, Lee C, Paik I H. Ban I polymorphism of the cytosolic phospholipase A2 gene may confersusceptibility to the development of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28(4): 739–741

doi: 10.1016/j.pnpbp.2004.05.009
Chowdari K V, Brandstaetter B, Semwal P, Bhatia T, Deshpande S, Reddy R, Wood J, Weinberg C R, Thelma B K, Nimgaonkar V L. Association studies of cytosolic phospholipase A2 polymorphismsand schizophrenia among two independent family-based samples. Psychiatr Genet, 2001, 11(4): 207–212

doi: 10.1097/00041444-200112000-00005
Frieboes R M, Moises H W, Gattaz W F, Yang L, Li T, Liu X, Vetter P, Macciardi F, Hwu H G, Henn F. Lack of associationbetween schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2. Am J Med Genet, 2001, 105(3): 246–249

doi: 10.1002/ajmg.1262
[1] Lunxiu Qin. Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies[J]. Front Med, 2014, 8(1): 24-32.
[2] Qingqing Xu, Xi Wu, Yuyu Xiong, Qinghe Xing, Lin He, Shengying Qin. Pharmacogenomics can improve antipsychotic treatment in schizophrenia[J]. Front Med, 2013, 7(2): 180-190.
[3] Renling Pei, Ye Xu, Yan Wei, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie. Association of SIPA1 545 C>T polymorphism with survival in Chinese women with metastatic breast cancer[J]. Front Med, 2013, 7(1): 138-142.
[4] Xiu-Liang TAO MM, Sheng-Hao TU MD, Ri-Bo XIONG MM, Yong-Hong HU BM, . Inhibition of TNF-alpha secretion from peripheral blood monocular cells by triptolid is associated with TNF-alpha-308 gene polymorphisms in rheumatoid arthritis patients[J]. Front. Med., 2010, 4(2): 220-224.
[5] Li-Feng LIU MD, PhD, Qiong CHEN MD, PhD, Ying CHANG MD, PhD, Ju-Sheng LIN MD, PhD, Jin-Liang ZHANG MM, . Cyclooxygenase-2 gene-1195G/A genotype is associated with the risk of HBV-induced HCC: A case-control study in Han Chinese people[J]. Front. Med., 2010, 4(1): 90-95.
[6] Dian-Ke YU PhD, Chen WU MD, Wen TAN MD, Dong-Xin LIN MD, . Functional XPF polymorphisms associated with lung cancer susceptibility in a Chinese population[J]. Front. Med., 2010, 4(1): 82-89.
[7] Dai-Hai YU PhD, Jian-Feng HUANG MD, Ji-Chun CHEN MS, Jie CAO MS, Shu-Feng CHEN PhD, Dong-Feng GU MD, PhD, for the GenSalt Collaborative Research Group, De-Pei LIU PhD, Lai-Yuan WANG PhD, Jing CHEN MD, MSc, Jiang HE MD, PhD, Cashell E. JAQUISH PhD, Dabeeru C. RAO PhD, Charles GU PhD, James E. HIXSON PhD, Chung-Shiuan CHEN MS8, Paul K. WHELTON MD, MSc9, . Genetic variants in the ADD1 and GNB3 genes and blood pressure response to potassium supplementation[J]. Front. Med., 2010, 4(1): 59-66.
[8] Chen WANG PhD, MD, Zhen-Guo ZHAI PhD, MD, Ying H. SHEN PhD, MD, Lan ZHAO PhD, MD, . Clinical and genetic risk factors for venous thromboembolism in Chinese population[J]. Front. Med., 2010, 4(1): 29-35.
[9] Ripen NSENGA MD, Longxian CHENG PhD, Mei’an HE PhD, Tangchun WU PhD, . The role of natriuretic peptide precursor A gene polymorphism in the development of coronary heart disease in Chinese Han population?[J]. Front. Med., 2009, 3(4): 437-442.
[10] QU Yanchun, YANG Ze, SUN Liang, JI Linong. 662 A/G gene variation in human tumor necrosis factor receptor superfamily, member 9 (TNFRSF9)[J]. Front. Med., 2008, 2(3): 283-285.
[11] WANG Hongxing, ZHANG Mingdao, CHEN Xingshi, LOU Feiying, LIANG Jianhua, CHEN Chong, SHI Tiantao, LU Qiulin. P50 auditory sensory gating in first onset schizophrenics and normal healthy adults[J]. Front. Med., 2007, 1(4): 429-432.
[12] XU Leping, JI Juying, DUAN Yiyang, SHI Hui, ZHANG Bin, SHAO Yaqin, SUN Jian. Abnormal glycosylated hemoglobin as a predictive factor for glucose metabolism disorders in antipsychotic treatment[J]. Front. Med., 2007, 1(3): 316-319.
[13] SUN Pin, ZHANG Zhongbin, WU Fen, WAN Junxiang, JIN Xibeng, XIA Zhaolin. Association of the genetic polymorphism of EPHX1 and EPHX2 with the susceptibility to chronic benzene poisoning[J]. Front. Med., 2007, 1(3): 320-326.
[14] JING Jianying, WANG Dan, WANG Xiaofeng, JIN Jianzhong, JIN Li, JIAO Yi, WEN Hao, LIN Renyong. Association study on GNB3 gene polymorphism with essential hypertension in Xinjiang Uygur group[J]. Front. Med., 2007, 1(2): 230-233.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed